The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).
 
Katherine Sanchez
No Relationships to Disclose
 
Shu-Ching Chang
No Relationships to Disclose
 
Isaac Kim
No Relationships to Disclose
 
Maritza Martel
No Relationships to Disclose
 
Yaping Wu
No Relationships to Disclose
 
William L Redmond
Research Funding - Aeglea Biotherapeutics; Bristol-Myers Squibb; Galectin Therapeutics; MedImmune; Merck; Nektar; Tesaro; Ventana Medical Systems
 
Zhaoyu Sun
No Relationships to Disclose
 
Dottie Waddell
No Relationships to Disclose
 
Deborah R. Laxague
No Relationships to Disclose
 
Brady Bernard
No Relationships to Disclose
 
Monil Shah
Employment - Brooklyn ImmunoTherapeutics; Pfizer; WindMIL
Leadership - Brooklyn ImmunoTherapeutics; Pfizer; WindMIL
Consulting or Advisory Role - Brooklyn ImmunoTherapeutics
 
Walter John Urba
Leadership - Leidos Biomedical Research
Stock and Other Ownership Interests - Pfizer
Honoraria - Bristol-Myers Squibb; Celldex; MedImmune; Newlink Genetics; OncoSec
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Celldex; Etherna; GreenPeptide; MedImmune (Inst); Newlink Genetics; OncoSec
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Galectin Therapeutics (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - Agonox; Bristol-Myers Squibb; Etherna; Leidos Biomedical Research; MedImmune
 
David B. Page
Honoraria - Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; NanoString Technologies; NanoString Technologies; Nektar; Puma Biotechnology; Puma Biotechnology; Syndax
Speakers' Bureau - Genentech/Roche
Research Funding - Bristol-Myers Squibb; MedImmune (Inst); Merck
Expert Testimony - Philips Healthcare
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune